Valneva SE
- Last sale
- Nov 12, 2026 · -2.37%
- Market cap
- $499.79M
- 86.77M shares
- Filings
- 270
FY 2025+3.0% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−34.8% FY25 yoy
- $499.79M
- —
- —
- —
- —
- —
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | €174,659,000 | reported | |
| FY 2024 | 2024-12-31 | €169,579,000 | reported | |
| FY 2023 | 2023-12-31 | €153,713,000 | reported | |
| FY 2022 | 2022-12-31 | €361,303,000 | reported | |
| FY 2021 | 2021-12-31 | €348,086,000 | reported | |
| FY 2020 | 2020-12-31 | €110,321,000 | reported | |
| FY 2019 | 2019-12-31 | €126,196,000 | reported |
Segments
LineFY2022ShareChange
COVID€309.58M86%+22.2%
Commercialized products€85.25M24%+35.3%
Vaccine candidates€5.57M1.5%+70.9%
Technologies and services-€39.09M—N/M
Total€361.30M
Biological products, except diagnostic substances
Valneva SE is the 64th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
GRMLGreenland Mines Ltd———$612.4MSRZNSurrozen, Inc.$3.5M67.4%6,960.8%$605.8MSANASana Biotechnology, Inc.———$599.3METRAElectra Therapeutics, Inc.———$574.6MENTXEntera Bio Ltd.$42.0K76.8%27,235.7%$559.9MRGNXRegenxbio Inc.$170.4M104.5%113.8%$531.0M
VALNValneva SE (this company)———$499.8M
JSPRJasper Therapeutics, Inc.———$445.9MTECXTectonic Therapeutic, Inc.———$436.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Valneva SE · CIK 1836564 · Engraved from SEC EDGAR